By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Oncology development activities62.9M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
Japan28.83M45.83%
United States24.66M39.21%
China9.41M14.96%